Pharmaceutical companies are the most willing to pay for money in the world.

Top-down numbers, from Pfizer Pharmaceuticals to Bella Pharmaceutical Factory in Mozambique, are among the top in various industries.

Simply put, the more profitable and bad-famous a company, the more it needs a large amount of extra expenses to maintain an already collapsed image and protect fragile ecological chains, such as arms dealers, energy companies or pharmaceutical companies.

On the other hand, the larger the company's scale and the greater the degree of cross-border and regional, the more it needs to bet resources in it.

Why is Coca-Cola willing to pay tens of thousands of dollars to Yang Rui to make an investment that is not in their plan? Because it is too common to spend tens of thousands of dollars on their marketing plans to hold a meeting and do a project. Even Coca-Cola companies in China are willing to spend a lot of cash when they find a suitable project.

Sometimes such multinational companies would pay tens of thousands of dollars to an unknown scholar in exchange for his "righteousness", or simply a speech to the crowd that doesn't care. The round-trip first-class air tickets and hotel expenses, plus lecture expenses, are enough to be shocking.

Pharmaceutical companies are even more courageous.

When a company spends tens of millions of dollars a year on average for various litigation, they are more generous in maintaining relationships than an average factory's annual output value.

Sometimes, for a lobbying involving new drugs, pharmaceutical companies can take out hundreds of millions of dollars from their pockets.

Astra is also one of the world's original pharmaceutical companies. It pays countless taxes to the Swedish government every year, and the turnover of selling drugs can be hundreds of billions of yuan per year.

For pharmaceutical companies of this level, the first thing they need to care about is the research and development of drugs and the launch of new drugs.

In fact, compared with small pharmaceutical companies, large pharmaceutical companies may not have stronger R&D capabilities. The way they are most accustomed to is to purchase patents from small pharmaceutical companies and use their strong marketing capabilities and government relations to promote drugs.

However, drug patents are only one link in drug research and development.

When they reach Astra's level, they not only have to care about what new drugs have come out, but also what new drugs we can make now.

What new drugs can be made depends on the development and initiatives of basic medicine.

For example, G protein-coupled receptors are the source of new drugs for a long time in the future. At one time, 50% of new drugs were made efforts in G protein-coupled receptors.

Astra was naturally unwilling to accept the situation, so they grabbed the olive branch Yang Rui handed over.

Companies like large pharmaceutical companies are not afraid of you making requirements, and this is even more so for pharmaceutical companies in Sweden.

Yang Rui is not the first biologist interested in the Nobel Prize, nor will he be the last one.

After visiting the simple pharmaceutical factory that day, without Yang Rui or Zhou Yingyao, the Astra official who was in charge of the itinerary and introduced came over and said, "Mr. Yang Rui, I heard that your Chinese Embassy is going to hold a dinner. I have signed up."

"Oh, thank you for your participation." Yang Rui showed considerable enthusiasm.

"I'll introduce myself, Pulitzer. I'm from Stockholm. When I was a child, my favorite festival every year was the Nobel Prize ceremony." Pulitzer smiled and said, "Stockholm was the most lively place at that time. We drank, laughed, and watched real scientists win awards together."

Yang Rui nodded slightly.

"There is a saying that even the most lively Swedes are not as shy as the most outgoing Americans, except after drinking." Pulitzer raised the wine glass he held in his hand and said, "Mr. Yang Rui, Astra believes that your research on G-protein coupling receptors and PCR has a commendable originality and commendable influence. You deserve the Nobel Prize."

"That's how Astra thinks?"

"certainly."

"Thank you very much for your appreciation." Yang Rui couldn't help but look up. This is the meaning of his coming to Sweden. He has to tell people that there are people here who are qualified to win the Nobel Prize, and this person is willing to win the Nobel Prize.

However, Astra was originally the easiest Swedish company to conquer. Their relationship with Jelikan and their lack of integrity as a pharmaceutical company all determined that they were more willing to support Yang Rui. However, from the perspective of stepping stones, Astra has made it very meaningful again.

Yang Rui also said kindly: "The attitude of Astra Company is very important to me. Mr. Pulitzer, you are the first company I have come into contact with in Sweden and the first company to give me full support. Thank you very much."

Pulitzer smiled very Swedishly, quickly restrained himself and said, "Mr. Yang Rui, I want to make a point that it cannot be called the full support of Astra Company. Of course, we support you very much..."

"Under what conditions will you fully support?" Faced with such multinational companies, even Swedish multinational companies, Yang Rui doesn't have to maintain the so-called celebrity style.

Commercial companies are companies that pay attention to transactions, and Yang Rui is also a person with capital.

Pulitzer glanced at Yang Rui in surprise and said, "Your approach reminds me of Americans, oh, no, it should be more like British."

"oh?"

"The British always discuss some very important issues in a plain tone."

"So the British 007 is very famous." Yang Rui smiled and said, "I think the Swedes are always very calm."

"It's better to say it's indifference." Pulitzer changed the topic and said, "Mr. Yang Rui, if Astra fully supports you, what kind of reward can you provide."

"I can give your researchers a month's class and answer their questions." Yang Rui said.

Pulitzer was stunned for a moment, couldn't help laughing, and said, "Mr. Yang Rui, you are a joke telling person."

"Not a joke, Mr. Pulitzer."

Pulitzer said with a stern face: "Mr. Yang Rui, I would rather think it is a joke. Astra is a large pharmaceutical company with many years of tradition and confidence. We are willing to accept information from the outside world and discuss with researchers from other countries, but..."

"It only took me two months to make deferrosterone." Yang Rui did not let him finish speaking and interrupted: "And I made 7 active substances. Now it seems that the third phase clinical trial is also very smooth, and the fourth phase clinical trial is even more problematic..."

Pulitzer was suddenly a little exhausted. Making original innovative drugs is a big deal for any large company. Although Astra is a large company with a marketing of tens of billions of dollars, they can pass original innovative drugs every year - in fact, no large company can have original innovative drugs every year. In terms of drug development, cruelty is the norm.

"Think about it." Yang Rui's voice was tempting, and he said: "I am the researcher who knows G protein-coupled receptors the most in the world. Although I feel a little embarrassed to brag about this, do you think my positioning is appropriate?"

"I think it's very appropriate." Pulitzer said this strongly, and the thoughts in his mind instantly emerged.

The reason why the research on G protein coupled receptors is called Wangqi is because its seven-time transmembrane mechanism is too abnormal. It affects almost all aspects of the human body, from smell to life maintenance...

In other words, G protein coupling receptors can affect all aspects of the human body, and the resulting targets are countless.

And Yang Rui, he is a man holding the king's flag.

Although the news that Yang Rui has completed the second phase of G protein-coupled receptor has not been heard yet, and Pulitzer does not know, but no one can copy his progress in the first phase.

In other words, Yang Rui is the well-deserved first person in G protein-coupled receptors.

What's even more rare is that he is not a biologist who only knows basic research, he also presided over the development of a new drug.

Such an experience made Pulitzer very envious.

"Full support is a big topic." Pulitzer's expression became serious, saying, "I don't have the right to make a decision, but I can report to the CEO."

Sweden is the country that most advocates flat management, and many people are qualified to report to the highest level.

Yang Rui nodded, laughed again, and said, "You don't have to be too nervous. Maybe you can arrange your time first and let me have some in-depth conversations with your researchers, such as the form of a lecture?"

"Would you like this?"

"certainly."

"Great, thank you very much." Pulitzer immediately agreed: "I will make the corresponding arrangements right away... Oh, do you want to name the lecture?"
Chapter completed!